APO RESEARCH · REPORT
AI Medical Imaging Software for Cardiovascular Disease
Selected research
Industry Research
AI Medical Imaging Software for Cardiovascular Disease Industry Research Report 2026
Market perspective
The global AI Medical Imaging Software for Cardiovascular Disease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Medical Imaging Software for Cardiovascular Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Medical Imaging Software for Cardiovascular Disease market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Medical Imaging Software for Cardiovascular Disease market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Medical Imaging Software for Cardiovascular Disease include Siemens, United-Imaging, Deepwise, Atrui Technology, Lepu Medical, Keya Medical, RaysightMed, Shukun Technology and Infervision Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Medical Imaging Software for Cardiovascular Disease market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Medical Imaging Software for Cardiovascular Disease.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Medical Imaging Software for Cardiovascular Disease Market by Company
Siemens
United-Imaging
Deepwise
Atrui Technology
Lepu Medical
Keya Medical
RaysightMed
Shukun Technology
Infervision Medical
Yizhun Intelligent
Pulse Medical
Fosun Aitrox
Edan Instruments
Thoth Medical
Nalong Health
AI Medical Imaging Software for Cardiovascular Disease Segment by Type
Cloud-Based
On-Premise
AI Medical Imaging Software for Cardiovascular Disease Segment by Application
Hospital
Clinic
AI Medical Imaging Software for Cardiovascular Disease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Cardiovascular Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Cardiovascular Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Cardiovascular Disease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Medical Imaging Software for Cardiovascular Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- On-Premise
Applications
- Hospital
- Clinic
Companies covered
- Siemens
- United-Imaging
- Deepwise
- Atrui Technology
- Lepu Medical
- Keya Medical
- RaysightMed
- Shukun Technology
- Infervision Medical
- Yizhun Intelligent
- Pulse Medical
- Fosun Aitrox
- Edan Instruments
- Thoth Medical
- Nalong Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Medical Imaging Software for Cardiovascular Disease by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-Based
- 2.2.3 On-Premise
- 2.3 AI Medical Imaging Software for Cardiovascular Disease by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 AI Medical Imaging Software for Cardiovascular Disease Breakdown Data by Type
- 3.1 Global AI Medical Imaging Software for Cardiovascular Disease Historic Market Size by Type (2021-2026)
- 3.2 Global AI Medical Imaging Software for Cardiovascular Disease Forecasted Market Size by Type (2027-2032)
4 AI Medical Imaging Software for Cardiovascular Disease Breakdown Data by Application
- 4.1 Global AI Medical Imaging Software for Cardiovascular Disease Historic Market Size by Application (2021-2026)
- 4.2 Global AI Medical Imaging Software for Cardiovascular Disease Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Perspective (2021-2032)
- 5.2 Global AI Medical Imaging Software for Cardiovascular Disease Growth Trends by Region
- 5.2.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Medical Imaging Software for Cardiovascular Disease Historic Market Size by Region (2021-2026)
- 5.2.3 AI Medical Imaging Software for Cardiovascular Disease Forecasted Market Size by Region (2027-2032)
- 5.3 AI Medical Imaging Software for Cardiovascular Disease Market Dynamics
- 5.3.1 AI Medical Imaging Software for Cardiovascular Disease Industry Trends
- 5.3.2 AI Medical Imaging Software for Cardiovascular Disease Market Drivers
- 5.3.3 AI Medical Imaging Software for Cardiovascular Disease Market Challenges
- 5.3.4 AI Medical Imaging Software for Cardiovascular Disease Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Medical Imaging Software for Cardiovascular Disease Players by Revenue
- 6.1.1 Global Top AI Medical Imaging Software for Cardiovascular Disease Players by Revenue (2021-2026)
- 6.1.2 Global AI Medical Imaging Software for Cardiovascular Disease Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Medical Imaging Software for Cardiovascular Disease Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Medical Imaging Software for Cardiovascular Disease Head Office and Area Served
- 6.4 Global AI Medical Imaging Software for Cardiovascular Disease Players, Product Type & Application
- 6.5 Global AI Medical Imaging Software for Cardiovascular Disease Manufacturers Established Date
- 6.6 Global AI Medical Imaging Software for Cardiovascular Disease Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
- 7.2 North America AI Medical Imaging Software for Cardiovascular Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
- 7.4 North America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
- 8.2 Europe AI Medical Imaging Software for Cardiovascular Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
- 8.4 Europe AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
- 9.2 Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
- 10.2 South America AI Medical Imaging Software for Cardiovascular Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
- 10.4 South America AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
- 11.2 Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens
- 12.1.1 Siemens Company Information
- 12.1.2 Siemens Business Overview
- 12.1.3 Siemens Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.1.4 Siemens AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.1.5 Siemens Recent Developments
- 12.2 United-Imaging
- 12.2.1 United-Imaging Company Information
- 12.2.2 United-Imaging Business Overview
- 12.2.3 United-Imaging Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.2.4 United-Imaging AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.2.5 United-Imaging Recent Developments
- 12.3 Deepwise
- 12.3.1 Deepwise Company Information
- 12.3.2 Deepwise Business Overview
- 12.3.3 Deepwise Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.3.4 Deepwise AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.3.5 Deepwise Recent Developments
- 12.4 Atrui Technology
- 12.4.1 Atrui Technology Company Information
- 12.4.2 Atrui Technology Business Overview
- 12.4.3 Atrui Technology Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.4.4 Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.4.5 Atrui Technology Recent Developments
- 12.5 Lepu Medical
- 12.5.1 Lepu Medical Company Information
- 12.5.2 Lepu Medical Business Overview
- 12.5.3 Lepu Medical Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.5.4 Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.5.5 Lepu Medical Recent Developments
- 12.6 Keya Medical
- 12.6.1 Keya Medical Company Information
- 12.6.2 Keya Medical Business Overview
- 12.6.3 Keya Medical Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.6.4 Keya Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.6.5 Keya Medical Recent Developments
- 12.7 RaysightMed
- 12.7.1 RaysightMed Company Information
- 12.7.2 RaysightMed Business Overview
- 12.7.3 RaysightMed Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.7.4 RaysightMed AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.7.5 RaysightMed Recent Developments
- 12.8 Shukun Technology
- 12.8.1 Shukun Technology Company Information
- 12.8.2 Shukun Technology Business Overview
- 12.8.3 Shukun Technology Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.8.4 Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.8.5 Shukun Technology Recent Developments
- 12.9 Infervision Medical
- 12.9.1 Infervision Medical Company Information
- 12.9.2 Infervision Medical Business Overview
- 12.9.3 Infervision Medical Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.9.4 Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.9.5 Infervision Medical Recent Developments
- 12.10 Yizhun Intelligent
- 12.10.1 Yizhun Intelligent Company Information
- 12.10.2 Yizhun Intelligent Business Overview
- 12.10.3 Yizhun Intelligent Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.10.4 Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.10.5 Yizhun Intelligent Recent Developments
- 12.11 Pulse Medical
- 12.11.1 Pulse Medical Company Information
- 12.11.2 Pulse Medical Business Overview
- 12.11.3 Pulse Medical Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.11.4 Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.11.5 Pulse Medical Recent Developments
- 12.12 Fosun Aitrox
- 12.12.1 Fosun Aitrox Company Information
- 12.12.2 Fosun Aitrox Business Overview
- 12.12.3 Fosun Aitrox Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.12.4 Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.12.5 Fosun Aitrox Recent Developments
- 12.13 Edan Instruments
- 12.13.1 Edan Instruments Company Information
- 12.13.2 Edan Instruments Business Overview
- 12.13.3 Edan Instruments Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.13.4 Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.13.5 Edan Instruments Recent Developments
- 12.14 Thoth Medical
- 12.14.1 Thoth Medical Company Information
- 12.14.2 Thoth Medical Business Overview
- 12.14.3 Thoth Medical Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.14.4 Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.14.5 Thoth Medical Recent Developments
- 12.15 Nalong Health
- 12.15.1 Nalong Health Company Information
- 12.15.2 Nalong Health Business Overview
- 12.15.3 Nalong Health Revenue in AI Medical Imaging Software for Cardiovascular Disease Business (2021-2026)
- 12.15.4 Nalong Health AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
- 12.15.5 Nalong Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst